- Home
- CVAC vs DMRC Comparison
CVAC vs DMRC Comparison
Compare CVAC & DMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- DMRC
- Stock Information
- Founded
- CVAC 2000
- DMRC 2008
- Country
- CVAC Germany
- DMRC United States
- Employees
- CVAC N/A
- DMRC N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- DMRC EDP Services
- Sector
- CVAC Health Care
- DMRC Technology
- Exchange
- CVAC Nasdaq
- DMRC Nasdaq
- Market Cap
- CVAC 637.1M
- DMRC 748.5M
- IPO Year
- CVAC 2020
- DMRC N/A
- Fundamental
- Price
- CVAC $2.95
- DMRC $38.45
- Analyst Decision
- CVAC Hold
- DMRC Buy
- Analyst Count
- CVAC 3
- DMRC 3
- Target Price
- CVAC $10.00
- DMRC $34.00
- AVG Volume (30 Days)
- CVAC 523.1K
- DMRC 134.3K
- Earning Date
- CVAC 11-12-2024
- DMRC 11-14-2024
- Dividend Yield
- CVAC N/A
- DMRC N/A
- EPS Growth
- CVAC N/A
- DMRC N/A
- EPS
- CVAC N/A
- DMRC N/A
- Revenue
- CVAC $70,565,734.00
- DMRC $39,044,000.00
- Revenue This Year
- CVAC $738.59
- DMRC $22.36
- Revenue Next Year
- CVAC N/A
- DMRC $20.74
- P/E Ratio
- CVAC N/A
- DMRC N/A
- Revenue Growth
- CVAC 75.11
- DMRC 19.09
- 52 Week Low
- CVAC $2.22
- DMRC $21.00
- 52 Week High
- CVAC $5.28
- DMRC $43.43
- Technical
- Relative Strength Index (RSI)
- CVAC 49.55
- DMRC 67.54
- Support Level
- CVAC $3.17
- DMRC $33.98
- Resistance Level
- CVAC $3.56
- DMRC $37.99
- Average True Range (ATR)
- CVAC 0.18
- DMRC 1.82
- MACD
- CVAC 0.01
- DMRC 0.20
- Stochastic Oscillator
- CVAC 24.69
- DMRC 91.63
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers, and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.